Details for Patent: 5,576,328
✉ Email this page to a colleague
Summary for Patent: 5,576,328
Title: | Method for the secondary prevention of ischemic events |
Abstract: | The invention relates to a new method for the secondary prevention of ischemic events comprising administering to a man in need thereof a therapeutically effective amount of a compound selected from clopidogrel and its pharmaceutically acceptable acid addition salts in association with a pharmaceutically acceptable carrier. |
Inventor(s): | Herbert; Jean-Marc (Tournefeuille, FR), Frehel; Daniel (Toulouse, FR), Bernat; Andr e (Cugnaux, FR), Badorc; Alain (Roquettes, FR), Savi; Pierre (Seysses, FR), Delebass ee; Denis (Goyrans, FR), Kieffer; Gilles (Montpellier, FR), Defreyn; Ghislain (Eaunes, FR), Maffrand; Jean-Pierre (Portet/Garonne, FR) |
Assignee: | Elf Sanofi (Paris, FR) |
Application Number: | 08/190,332 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 5,576,328
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |